Physiologic Pacing Registry

Sponsor
Abbott Medical Devices (Industry)
Overall Status
Completed
CT.gov ID
NCT03719040
Collaborator
(none)
870
50
34.3
17.4
0.5

Study Details

Study Description

Brief Summary

The Physiologic Pacing Registry is a prospective, observational, multi-center registry performed to gain a broader understanding of 1) physiologic pacing implant and follow-up workflows, including pacing and sensing measurements and 2) the clinical utility in creating a 3-dimensional electro-anatomical map of cardiac structures prior to physiologic pacing device implants based on the clinical site's routine care.

Condition or Disease Intervention/Treatment Phase
  • Device: Physiologic pacing device implant

Detailed Description

The Physiologic Pacing Registry will be conducted to gain a deeper understanding of physiologic pacing device implants and follow-up workflows, including device and programmer measurements to help inform Abbott's product and clinical data development efforts. Additionally, the registry will provide a broader understanding of the clinical utility in mapping physiologic pacing structures with the use of Abbott's EnSite Cardiac Mapping System with an electrophysiology catheter prior to device implants for those institutions where mapping is routine care prior to physiologic pacing device implant.

The registry will include patients undergoing implantation of an Abbott pacemaker, defibrillator, or a cardiac resynchronization therapy (CRT) pacemaker (CRT-P) or CRT defibrillator (CRT-D) according to the clinical site's routine care. Only patients scheduled to receive an Abbott device may be enrolled to ensure proper device data collection for future software and other physiologic pacing product development. The decision to provide physiologic pacing therapy and selection of devices for implant are at the discretion of the implanting physician. Abbott will collect data on the use of all commercially available leads and associated implant tools based on the physician's discretion as part of routine clinical practice within the registry.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
870 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Physiologic Pacing Registry
Actual Study Start Date :
Nov 27, 2018
Actual Primary Completion Date :
Oct 7, 2021
Actual Study Completion Date :
Oct 7, 2021

Outcome Measures

Primary Outcome Measures

  1. Physiologic pacing device implant characteristics [During procedure]

    Data will be collected to characterize the workflow, success, and complications associated with standard-of-care HBP implants in patients indicated for a pacemaker, defibrillator, or CRT device. Data will be compared with and without the use of the EnSite Precision Mapping System used according to each site's routine care.

  2. Physiologic pacing device implant follow-up characteristics [6 Months]

    Data will be collected to characterize the workflow, device system electrical performance and programming, and adverse events associated with HBP implants.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  1. Scheduled for implantation of an Abbott pacemaker, defibrillator, or CRT-P/D device with any commercially available pacing lead as part of a physiologic pacing procedure according to the clinical site's routine care.

  2. At least 18 years of age.

  3. Willing and able to comply with the prescribed follow-up tests and schedule of evaluations.

  4. Provided written informed consent prior to any registry-related procedures.

Exclusion Criteria:
  1. History of tricuspid valve repair or replacement.

  2. Currently participating in another clinical study with an active treatment arm and belong to the active arm

  3. Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the registry or to comply with follow-up requirements, or impact the scientific soundness of the registry results.

  4. Chronic physiologic pacing lead implanted

  5. Life expectancy of < 6 months.

  6. Known contraindication for physiologic pacing therapy/implant (i.e. ongoing infection, known occlusion of the subclavian vein, etc.).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Heart Center Research, LLC. Huntsville Alabama United States 35801
2 Mills-Peninsula Medical Center Burlingame California United States 94010
3 University of California at San Diego (UCSD) Medical Center San Diego California United States 92103
4 Yoel R. Vivas, MD Delray Beach Florida United States 33484
5 Usman R. Siddiqui, MD Winter Park Florida United States 32792
6 Rush University Medical Center Chicago Illinois United States 60612
7 University of Chicago Chicago Illinois United States 60637
8 IU Health Bloomington Hospital Bloomington Indiana United States 47403
9 Iowa Heart Center West Des Moines Iowa United States 50266
10 Massachusetts General Hospital Boston Massachusetts United States 02114
11 Charlton Memorial Hospital Fall River Massachusetts United States 02720
12 Providence Hospital Southfield Michigan United States 48075
13 The Valley Hospital Ridgewood New Jersey United States 07450
14 New Mexico Heart Institute Albuquerque New Mexico United States 87102
15 New York University Hospital New York New York United States 10016
16 Duke University Medical Center Durham North Carolina United States 27705
17 Providence Heart & Vascular Institute Portland Oregon United States 97225
18 Geisinger Medical Center Danville Pennsylvania United States 17822-2150
19 Pinnacle Health System Harrisburg Pennsylvania United States 10016
20 Lancaster General Hospital Lancaster Pennsylvania United States 17602
21 Allegheny General Hospital - ASRI Pittsburgh Pennsylvania United States 15212
22 Donald Guthrie Foundation for Education and Research Sayre Pennsylvania United States 18840
23 Texas Cardiac Arrhythmia Austin Texas United States 78705
24 The Methodist Hospital Houston Texas United States 77030
25 University of Vermont College of Medicine Burlington Vermont United States 05405-0068
26 St. Joseph Medical Center Tacoma Washington United States 98405
27 The Northern Hospital Epping Victoria Australia 3076
28 Mulgrave Private Hospital Mulgrave Victoria Australia 3170
29 Fiona Stanley Hospital Murdoch Western Australia Australia 6150
30 Universitätsklinik Graz Graz Styria Austria 8036
31 QE II Health Sciences Halifax Nova Scotia Canada B3H 3A7
32 CHUS Fleurimont Sherbrooke Styria Canada 8036
33 Fakultni nemocnice Kralovske Vinohrady Prague Central Bohemia Czechia 100 34
34 Clinique Ambroise Pare Neuilly-sur-Seine Ile-de-France France 92200
35 CHRU Rouen Hospital Charles Nicolle Rouen Upper Normandy France 76031
36 Herzzentrum Leipzig GmbH Leipzig Saxony Germany 04286
37 Herz-und Diabetes Zentrum NRW Bad Oeynhausen Germany 32545
38 Prince of Wales Hospital Hong Kong Hong Kong SAR Hong Kong 999077
39 Fortis Memorial Research Institute Gurugram Haryana India 122002
40 Asian Institute of Gastroenterology (AIG) Hospital Hyderabad India 500032
41 Ospedale Generale Regionale F. Miulli Acquaviva Delle Fonti Italy 70021
42 Ospedale S.Maria della Misericordia Rovigo Italy 45100
43 Maastricht University Medical Center Maastricht Netherlands 6229 HX
44 Gornoslaskie Centrum Medyczne im.prof. Leszka Gieca Katowice Poland 40-635
45 National Heart Centre Singapore Singapore Central Singapore 169609
46 NG Teng Fong General Hospital Singapore Central Singapore 609606
47 Christiaan Barnard Memorial Hospital Cape Town South Africa 8001
48 Hospital Universitario Virgen de la Nieves Granada Spain 18014
49 Hospital General Juan Ramon Jimenez Huelva Spain 21005
50 Center Inselspital Bern Bern Switzerland 3010

Sponsors and Collaborators

  • Abbott Medical Devices

Investigators

  • Study Director: Clay Cohorn, Abbott

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Abbott Medical Devices
ClinicalTrials.gov Identifier:
NCT03719040
Other Study ID Numbers:
  • ABT-CIP-10270
First Posted:
Oct 25, 2018
Last Update Posted:
Jan 12, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 12, 2022